BCGM Wealth Management, LLC has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity holdings as of September 30, 2026. The filing lists 188 separate positions held by the firm.
The portfolio is heavily weighted toward exchange-traded funds (ETFs), comprising the majority of the disclosed holdings. Among the individual stock positions, AbbVie Inc. is the largest holding, with 912 shares. Other notable individual stock positions include Apple Inc. with 10,307 shares, Berkshire Hathaway Inc. Class B with 5,841 shares, and Eli Lilly & Co. with 8,940 shares.
The filing also details significant allocations to various ETFs. The BlackRock ETF Trust iShares Core S&P 500 ETF is listed with 228,674 shares. Other ETFs in the portfolio include the Vanguard Index Funds Morningstar Large Cap ETF with 121,81 shares, the Invesco QQQ Trust Unit Series 1 with 21,204 shares, and the iShares Gold Trust with 30,020 shares.
The report was signed by Andy Armstrong, the Chief Compliance Officer for BCGM Wealth Management, LLC, and was filed on November 10, 2026.
